WHO Global Summit charts a bold future for traditional medicine: Our Bureau, Mumbai Wednesday, December 24, 2025, 10:00 Hrs ...
Medanta enhances its cancer care programme with the latest Varian EDGE radiation machine: Our Bureau, Mumbai Wednesday, ...
InnoCare receives China NMPA approval to initiate phase II trial of TYK2 inhibitor ICP-488 for cutaneous lupus erythematosus: Beijing Wednesday, December 24, 2025, 18:00 Hrs [IST] ...
Emcure and MS Dhoni reignite India’s weight-loss conversation with ‘Winning Over Obesity’ campaign: Our Bureau, Mumbai Wednesday, December 24, 2025, 17:50 Hrs [IST] Emcure P ...
Sharda Hospital lead India’s digital healthcare shift by becoming fully paperless: Our Bureau, Bengaluru Wednesday, December 24, 2025, 17:30 Hrs [IST] Sharda Hospital has become ...
Gastroenterologists debunk common digestion & bowel health myths, urge lifestyle-based care: Our Bureau, Mumbai Wednesday, December 24, 2025, 17:40 Hrs [IST] As World Constipation ...
Care ADHD expands set up its 1st Global Capability Centre in India: Our Bureau, Bengaluru Wednesday, December 24, 2025, 17:15 Hrs [IST] Care ADHD, one of the United Kingdom’s fa ...
Australia and Indonesia achieve WHO Listed Authority status in medical products regulation: Geneva Wednesday, December 24, 2025, 17:00 Hrs [IST] The World Health Organization (WHO ...
Saarathi acquisition by QMS to create a unified product-plus-services ecosystem for hospitals, pharma cos: Shardul Nautiyal, Mumbai Wednesday, December 24, 2025, 15:45 Hrs [IST] Q ...
NIT Rourkela bags SPARC project of Rs. 95.16 lakh for research on wearable robotic devices: Exoskeletons: Our Bureau, Bengaluru Wednesday, December 24, 2025, 14:40 Hrs [IST] Natio ...
Ginkgo Bioworks and Carnegie-Mellon University partner to develop innovative new cancer screening approach: Boston Wednesday, December 24, 2025, 16:00 Hrs [IST] Ginkgo Bioworks, a ...
Samsung Bioepis’ ustekinumab biosimilar receives Japanese marketing approval: Incheon, Korea Wednesday, December 24, 2025, 15:00 Hrs [IST] Samsung Bioepis Co., Ltd., a biopharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results